Biodesix effects 1-for-20 reverse stock split, eliminates Series A preferred

BIODESIX INC

Reverse stock split at 1:20 ratio effective Sep 15, 2025; new CUSIP 09075X207.
No fractional shares issued; cash-in-lieu based on closing price before effective date.
Certificate of Elimination for Series A Non-Voting Convertible Preferred filed Sep 12, 2025.
Stockholder approval obtained May 20, 2025; Board set final ratio on Sep 4, 2025.

item 3.03item 5.03item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.